Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Pharmacologic and therapeutic strategies in treatment-resistant depression. Introduction and clinical presentations.

O'Reardon JP.

CNS Spectr. 2009 Mar;14(3 Suppl 4):4-6. No abstract available.

PMID:
19407713
2.

Bipolar II or unipolar depression: pharmacologic considerations.

Antai-Otong D.

Perspect Psychiatr Care. 2004 Jul-Sep;40(3):125-8. No abstract available.

PMID:
15515295
3.

[Treatment of depression with melitracen].

Puzyński S, Kalinowski A.

Wiad Lek. 1967 Oct 15;20(20):1859-64. Polish. No abstract available.

PMID:
4868392
4.

Pharmacologic and therapeutic strategies in treatment-resistant depression. Augmentation strategies.

Thase ME.

CNS Spectr. 2009 Mar;14(3 Suppl 4):7-10. No abstract available.

PMID:
19407714
5.
6.

A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder.

Papakostas GI, Petersen TJ, Perlis RH, Judy AE, Burns AM, Alpert JE, Birnbaum RJ, Fava M.

J Clin Psychopharmacol. 2006 Apr;26(2):216-8. No abstract available.

PMID:
16633159
7.

[Results of treatment of depressive states with melitracen].

Madejska N, Mika M, Pańkow T.

Psychiatr Pol. 1967 Jul-Aug;1(4):463-71. Polish. No abstract available.

PMID:
5595168
8.

[Some current aspects of antidepressive therapy].

Predescu V, Vianu I.

Neurol Psihiatr Neurochir. 1967 Nov-Dec;12(6):485-94. Romanian. No abstract available.

PMID:
5593224
9.

[Clinical experiences with the antidepressant Noveril in the treatment of depressions at a later age].

Arnold OH, Guss H.

Wien Klin Wochenschr. 1966 Dec 16;78(51):913-5. German. No abstract available.

PMID:
5973397
10.

[The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen].

Mashkovskii MD, Polezhaeva AI, Avrutskii GIa, Vertozgadova OP, Smulevich AB.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1969;69(8):1234-8. Russian. No abstract available.

PMID:
5392529
11.

[Influence of the seasons on the course and therapeutic results of depressive phases of maniomelancholy (author's transl)].

Sedivec V.

Cesk Psychiatr. 1981 Oct;77(5):326-30. Czech. No abstract available.

PMID:
7326778
12.

The modern pharmacopoeia: a return to depressive realism?

Goldberg JF.

Bipolar Disord. 2008 Dec;10(8):969-72. doi: 10.1111/j.1399-5618.2008.00632.x. No abstract available.

PMID:
19594511
13.

A critical overview of the pharmacologic management of treatment-resistant depression.

Nierenberg AA, Katz J, Fava M.

Psychiatr Clin North Am. 2007 Mar;30(1):13-29. Review.

PMID:
17362800
14.

Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.

Ghaemi SN.

Bipolar Disord. 2008 Dec;10(8):957-68. doi: 10.1111/j.1399-5618.2008.00639.x. Review.

PMID:
19594510
15.

Upping the ante on antidepressants.

Malhi GS.

Bipolar Disord. 2008 Dec;10(8):975-8. doi: 10.1111/j.1399-5618.2008.00645.x. No abstract available.

PMID:
19594513
16.

Management of patients with treatment-resistant depression.

Thase ME.

J Clin Psychiatry. 2008 Mar;69(3):e8.

17.

Diabetes and depression: pharmacologic considerations.

Antai-Otong D.

Perspect Psychiatr Care. 2007 Apr;43(2):93-6. No abstract available.

PMID:
17388852
18.

Antidepressant treatment practice in the face of STAR*D and STEP-BD.

Cassidy F.

Bipolar Disord. 2008 Dec;10(8):973-4. doi: 10.1111/j.1399-5618.2008.00631.x. No abstract available.

PMID:
19594512
19.

Effective agents in treating bipolar depression.

Nierenberg AA.

J Clin Psychiatry. 2008 Dec 3;69(10):e29. Review.

20.

Clinical trial of protriptyline (Vivactil).

Bercel NA.

Int J Neuropsychiatry. 1967 Aug;3(4):365-78. No abstract available.

PMID:
4863509

Supplemental Content

Support Center